Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
TheStreet.com
Monday, March 31, 2014 - 10:18am
tags:
Amgen, cholesterol, evolocumab
Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
First Word Pharma
Monday, March 31, 2014 - 9:59am
tags:
LCZ696, Novartis, heart failure
Mannkind: The Best Afrezza FDA Panel Preview Ever
TheStreet.com
Monday, March 31, 2014 - 9:53am
tags:
FDA, Afrezza, advisory panels, diabetes, MannKind
Oxygen Biotherapeutics Inc. Provides an Update on Communication with the FDA Regarding Oxycyte Development Program; Hold Has Been Lifted
Yahoo/Benzinga
Monday, March 31, 2014 - 9:44am
tags:
FDA, Oxygen Biotherapeutics, Oxycyte
Prana Alzheimer's Study Fails
TheStreet.com
Monday, March 31, 2014 - 9:38am
tags:
Prana Biotechnology, Alzheimer's disease, PBT2
$4B deal: J&J sells lab testing unit to Carlyle
USA Today
Monday, March 31, 2014 - 9:36am
tags:
JNJ, M&A, Carlyle, diagnostics, Ortho-Clinical Diagnostics
GSK CEO says success of heart drug 'an open question'
Yahoo/Reuters
Monday, March 31, 2014 - 9:35am
tags:
GSK, Pharma CEOs, darapladib, Andrew Witty, heart attack
Amgen Drug Slashes Bad Cholesterol Within Weeks of Treatment
Bloomberg
Sunday, March 30, 2014 - 10:35am
tags:
Amgen, cholesterol, evolocumab
Alimera Sciences resubmits Iluvien NDA to US FDA
Pharmabiz
Saturday, March 29, 2014 - 9:56am
tags:
Alimera, Iluvien, diabetic macular edema
US pharma excipients demand to reach $2 bn in 2018
Business Standard, India
Saturday, March 29, 2014 - 9:53am
tags:
Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR
Yahoo/BusinessWire
Saturday, March 29, 2014 - 9:36am
tags:
Pfizer, Nexium, OTC
Encouraging Data on Pfizer Cholesterol Drug
Yahoo/Zacks
Saturday, March 29, 2014 - 9:32am
tags:
Pfizer, cholesterol, bococizumab
FDA staff review raises questions about MannKind diabetes device
Yahoo/Reuters
Saturday, March 29, 2014 - 9:13am
tags:
MannKind, diabetes, type 2 diabetes
Does This Stock Warrant a $9 Billion Market Cap?
Motley Fool
Saturday, March 29, 2014 - 9:11am
tags:
Incyte
Biogen Wins Approval for Long-Lasting Hemophilia B Treatment
Bloomberg
Saturday, March 29, 2014 - 9:10am
tags:
Biogen Idec, Alprolix, hemophilia, hemophilia B
Endocyte Cancer Drug Is Prize Worth Top Premium: Real M&A
Bloomberg
Saturday, March 29, 2014 - 9:09am
tags:
Endocyte, vintafolide, lung cancer
Massachusetts bans sale of FDA-approved Zogenix painkiller
Yahoo/Reuters
Friday, March 28, 2014 - 1:03pm
tags:
Massachusetts, painkillers, Zogenix, Zohydro, hydrocodone
Arena - Scripts, Ads, Sales Reps
Seeking Alpha
Friday, March 28, 2014 - 1:01pm
tags:
Arena Pharmaceuticals, drug ads, drug reps, Belviq, Qsymia, Vivus
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
FOX Business
Friday, March 28, 2014 - 1:00pm
tags:
MannKind, FDA, Afrezza, insulin, diabetes
U.S. wants at least $1 billion from drugmakers who delay generics
Yahoo/Reuters
Friday, March 28, 2014 - 12:59pm
tags:
generics, pay-for-delay, FTC, Solvay, AbbVie, Actavis, Perrigo Company, Par Pharmaceutical, Teva, Cephalon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.